A Phase II Study of Sirolimus and Erlotinib in Recurrent/Refractory Germ Cell Tumors
Clinical trial NCT01962896 · TERMINATED
Trial details
- NCT number
- NCT01962896
- Sponsor
- Theodore Laetsch
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-01-08
- Primary completion
- 2017-06-13
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.